Skip to main content
Caplight Logo









Dongfang Lue

Dongfang Lue

Private
BeijingHealthcare & Life Scienceshttps://tonacea.com/

Last Round

Private Equity

Dec 23, 2019

Est. Valuation

$185.9M

Total Funding Raised

$42.9M

Company Overview

Dongfang Lue is a biopharmaceutical company focused on the research and development of DNA-based vaccines and therapies, notably for HPV-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Medical Devices, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

DNA vaccineelectroporationHPV treatmenttherapeutic vaccinedrug delivery devicebiopharmaceutical developmentclinical trialspharma licensingdrug commercializationbiotech consultingmarket intelligencebiopharma ecosystemgene therapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Dongfang Lue Comparables

Compare Dongfang Lue with similar companies based on industry and business-model similarity.

Dongfang Lue comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ApolloBio Corp.
94%
Luye Pharma Group
78%
Genexine Inc
76%

Dongfang Lue Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityDec 23, 2019
Private PlacementJan 1, 2017
Private PlacementJun 1, 2016
Private PlacementFeb 29, 2016
AngelJul 1, 2006

Dongfang Lue Investors

Notable investors and investment history

Dongfang Lue investors
InvestorRounds
Beijing Dongfang Gaosheng Holding Co., Ltd.Private Placement

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 23, 2019

    $43M round raised at $186M post-money valuation.

  • Jun 1, 2016

    Completed a private placement funding round.

Dongfang Lue Filings

Explore SEC and related filing metadata, where available.

Dongfang Lue filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Dongfang Lue's valuation, stock price, and market status.

Is Dongfang Lue a public or private company?

Dongfang Lue is a private company.

What is the current stock price of Dongfang Lue?

Dongfang Lue is a private company with no public stock price. No recent secondary market data is available.

How much is Dongfang Lue worth (valuation)?

Dongfang Lue's valuation is estimated at $185.9M based on funding round data.

Can I buy Dongfang Lue stock?

Dongfang Lue shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Dongfang Lue's last funding round?

Dongfang Lue's most recent funding round was Private Equity on December 23, 2019.

Who are the main investors in Dongfang Lue?

Key investors in Dongfang Lue include Beijing Dongfang Gaosheng Holding Co., Ltd..

Will Dongfang Lue IPO soon?

No public IPO plans have been announced for Dongfang Lue.

How can I track Dongfang Lue secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Dongfang Lue's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBeijing
Year FoundedN/A
Last FundingDec 23, 2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?